{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:56:53Z","timestamp":1785898613547,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011482","name":"Yantai Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012905","name":"Shandong Province Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajps.2026.101167","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:34:13Z","timestamp":1780119253000},"page":"101167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy"],"prefix":"10.1016","volume":"21","author":[{"given":"Xiaojing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1107-7437","authenticated-orcid":false,"given":"Zhenyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2026.101167_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008967","article-title":"ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM","volume":"12","author":"Long","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41401-021-00752-y","article-title":"Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle","volume":"43","author":"Ren","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ajps.2026.101167_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ajps.2026.101167_bib0005","first-page":"2585","article-title":"Temozolomide and treatment of malignant glioma","volume":"6","author":"Friedman","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ajps.2026.101167_bib0006","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat Immunol"},{"issue":"41","key":"10.1016\/j.ajps.2026.101167_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202513815","article-title":"A photon-driven unimolecular immunostimulant for self-amplified pyroptosis and cGAS-STING pathway by destroying the pyroptosis checkpoint","volume":"64","author":"Zeng","year":"2025","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.ajps.2026.101167_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123216","article-title":"Immunity\/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12\/CXCR4 and adenosine-A2AR pathways","volume":"319","author":"Wei","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajps.2026.101167_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.actbio.2024.12.027","article-title":"Mitochondrial transfer of drug-loaded artificial mitochondria for enhanced anti-glioma therapy through synergistic apoptosis\/ferroptosis\/immunogenic cell death","volume":"193","author":"Song","year":"2025","journal-title":"Acta Biomater"},{"issue":"21","key":"10.1016\/j.ajps.2026.101167_bib0011","doi-asserted-by":"crossref","first-page":"17902","DOI":"10.1021\/jacs.5c02731","article-title":"Engineering recombinant chimeric proteins that deliver therapies to the brain","volume":"147","author":"Zhang","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ajps.2026.101167_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"issue":"30","key":"10.1016\/j.ajps.2026.101167_bib0013","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403460121","article-title":"Bacterial outer membrane vesicle nanorobot","volume":"121","author":"Tang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajps.2026.101167_bib0014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: an update","volume":"323","author":"Li","year":"2020","journal-title":"J Control Release"},{"issue":"15","key":"10.1016\/j.ajps.2026.101167_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418053","article-title":"Engineered bacterial outer membrane vesicles-based doxorubicin and CD47-siRNA co-delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma","volume":"37","author":"You","year":"2025","journal-title":"Adv Mater"},{"issue":"3","key":"10.1016\/j.ajps.2026.101167_bib0016","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1021\/acsami.2c18244","article-title":"Bioengineered bacterial membrane vesicles with multifunctional nanoparticles as a versatile platform for cancer immunotherapy","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.ajps.2026.101167_bib0017","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/ijms.116432","article-title":"Bioengineering modification and application of bacterial outer membrane vesicles","volume":"23","author":"Wen","year":"2026","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ajps.2026.101167_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102573","article-title":"RVG29-modified oncolytic herpes simplex virus for intracranial tumor treatment","volume":"61","author":"Chen","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.ajps.2026.101167_bib0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.actbio.2025.10.025","article-title":"Virus-inspired nanocages potentiate glioblastoma sonochemotherapy via structure-function mimicry","volume":"207","author":"Liu","year":"2025","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2026.101167_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10395","article-title":"Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer\u2019s disease treatment and diagnosis","volume":"7","author":"Zhou","year":"2022","journal-title":"Bioeng Trans Med"},{"key":"10.1016\/j.ajps.2026.101167_bib0021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","article-title":"A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson\u2019s disease","volume":"277","author":"Qu","year":"2018","journal-title":"J Controlled Release"},{"key":"10.1016\/j.ajps.2026.101167_bib0022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12951-025-03406-x","article-title":"Oxidative stress induced paclitaxel-derived carbon dots inhibit glioblastoma proliferation and EMT process","volume":"23","author":"Yan","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.ajps.2026.101167_bib0023","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ajps.2026.101167_bib0024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1475-2859-11-118","article-title":"A dual tag system for facilitated detection of surface expressed proteins in Escherichia coli","volume":"11","author":"Jarmander","year":"2012","journal-title":"Microb Cell Fact"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood-brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101167_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101167_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114254","article-title":"Virus-inspired nanozymes for two-dimensional biomimetic penetration and long-acting ferroptosis inhibition in treating dry eye disease","volume":"387","author":"Bao","year":"2025","journal-title":"J Control Release"},{"issue":"22","key":"10.1016\/j.ajps.2026.101167_bib0028","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12951-023-01842-1","article-title":"Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug","volume":"21","author":"Song","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-023-01776-8","article-title":"Ultrasound targeted microbubble destruction-triggered nitric oxide release via nanoscale ultrasound contrast agent for sensitizing chemoimmunotherapy","volume":"21","author":"Zhao","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"41","key":"10.1016\/j.ajps.2026.101167_bib0031","doi-asserted-by":"crossref","first-page":"17218","DOI":"10.1039\/D1NR05512G","article-title":"Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.ajps.2026.101167_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201307","article-title":"Nano delivery of chemotherapeutic ICD inducers for tumor immunotherapy","volume":"7","author":"Guo","year":"2023","journal-title":"Small Methods"},{"issue":"8","key":"10.1016\/j.ajps.2026.101167_bib0033","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2\u03b1 phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ"},{"issue":"41","key":"10.1016\/j.ajps.2026.101167_bib0034","doi-asserted-by":"crossref","first-page":"37641","DOI":"10.1021\/jacs.5c12775","article-title":"Genetically engineered biomimetic nanoparticles for synergistic activation of glioma-associated macrophages against glioblastoma","volume":"147","author":"Luo","year":"2025","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.ajps.2026.101167_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/pharmaceutics17010058","article-title":"Innovative strategies in oncology: bacterial membrane vesicle-based drug delivery systems for cancer diagnosis and therapy","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101167_bib0036","article-title":"Bacterial outer membrane vesicles: from physics to clinical","volume":"4","author":"Zhou","year":"2025","journal-title":"MedComm \u2013 Biomater Appl"},{"issue":"6190","key":"10.1016\/j.ajps.2026.101167_bib0037","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ajps.2026.101167_bib0038","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","article-title":"Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model","volume":"4","author":"Reardon","year":"2016","journal-title":"Cancer Immunol Res"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808762600053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808762600053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:27:19Z","timestamp":1783682839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S181808762600053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S181808762600053X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101167","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101167"}}